Phytoceramides
Phytoceramides are plant-derived ceramides, extracted predominantly from rice, wheat, konjac, and peach sources. In their natural plant form, they exist as glucosylceramides (GlcCer) – ceramides with a glucose molecule at the head group – rather than as free ceramides. This glucosylated form is precisely what makes them orally bioavailable: the glucose attachment enables intestinal absorption through pathways unavailable to free ceramides, making phytoceramides one of the few genuinely evidence-supported routes to influencing skin ceramide status from within. [3]
How Oral GlcCer Reaches the Skin
The absorption pathway is more mechanistically involved than simply “oral ceramide reaches the skin.” Ingested glucosylceramides are partially hydrolysed by ceramidases in the small intestinal mucosa, releasing sphingosine, phytosphingosine, and fatty acid metabolites into portal circulation. Approximately half of the ingested substrate is absorbed this way. These metabolites are then taken up by keratinocytes, which incorporate them back into ceramide synthesis via the salvage pathway – the recycling route that regenerates usable ceramide from sphingolipid breakdown products without requiring de novo synthesis from scratch. MDPI
This mechanism has a significant implication: oral GlcCer does not deliver ceramides to the stratum corneum directly. It delivers the metabolic building blocks that keratinocytes use to upregulate their own ceramide production. The benefit is therefore biosynthetic rather than supplementary. Two different GlcCer species from rice have been shown to work through distinct mechanisms: one upregulates filaggrin and corneodesmosin expression (strengthening the protein scaffold and corneocyte cohesion), whilst another promotes glucosylceramide synthase expression, effectively encouraging the skin to make more of its own GlcCer precursors. Oral GlcCer also upregulates genes associated with cornified envelope formation and tight junction integrity in barrier-compromised skin, suggesting its effects extend beyond ceramide production alone. [1]
Evidence Base and Honest Expectations
The most cited clinical finding is a 12-week randomised study using 1.8mg daily of rice-derived glucosylceramides, which demonstrated 31.9% hydration improvement on the arm and 22.8% on the cheek compared with baseline. Complementary research with peach-derived GlcCer showed dose-dependent improvements in water retention and TEWL suppression following oral administration, with 3D human skin culture models confirming dose-dependent increases in stratum corneum ceramide content after GlcCer treatment. [2]
It is worth being transparent about where the evidence currently sits. Most robust data comes from rice and wheat sources in 8–12 week trials with consistent daily use. Dosing varies considerably between sources: rice-derived GlcCer trials have shown effects at relatively low doses of 1–40mg per day, whilst some wheat-derived formulations in clinical settings use 200mg or more daily. Effect sizes in hydration studies are meaningful but modest, and GlcCer’s contribution is best understood as complementary to topical approaches rather than equivalent to them. Topical ceramide formulations applied directly to the stratum corneum deliver structural lipids to the lamellar matrix immediately; oral GlcCer works upstream, improving the skin’s own synthesis capacity over weeks. Juniper Publishers
The fatty acid chain length of the ingested GlcCer species affects efficacy. Rice-derived GlcCer species with longer acyl chains demonstrated greater moisturising effects, consistent with what we know about chain length requirements in the stratum corneum itself. This is not something currently reflected in most supplement labelling, but it is relevant context when evaluating product quality. [4]
Source and Allergen Considerations
Wheat-derived phytoceramides raise a legitimate allergen consideration for clients with coeliac disease or wheat sensitivity, though the ceramide extract itself is typically processed to remove gluten proteins. Rice and konjac sources are naturally gluten-free and appropriate for this group. Sweet potato and peach sources have also demonstrated clinical evidence for oral ceramide effects, providing alternative options for clients with broader grain sensitivities. [3]
At Creative Touch, we discuss oral phytoceramides as part of an internal skin support strategy rather than a primary barrier repair tool. For clients with perimenopause-related ceramide decline, chronic barrier sensitivity, or those whose lifestyle makes consistent topical routine adherence difficult, oral GlcCer supplementation over a 12-week minimum period offers a meaningful contribution to the supply side of ceramide availability. The biosynthetic mechanism means the benefit builds gradually and compounds with a consistent topical approach rather than replacing it.
Clinical Application
Internal supplementation for skin barrier support works through different mechanisms than either topical products or professional treatments, and understanding that distinction helps frame realistic expectations for clients. Phytoceramides and omega-3 fatty acids are the two best-evidenced oral approaches to barrier lipid support, and they are meaningfully complementary because they target entirely different points in the same biological system.
How the Two Approaches Differ
Omega-3 fatty acids (EPA and DHA from fish or algal sources) work primarily through cytokine modulation – reducing the IL-4 and IL-13 inflammatory signalling that actively suppresses ceramide synthesis and fatty acid elongation in sensitised or chronically inflamed skin. Their barrier benefit is largely indirect: they remove the inflammatory brake that is preventing the skin’s own lipid production from functioning normally. For clients with atopic-tendency skin, perimenopausal sensitisation, or stress-related barrier deterioration, this is a meaningful contribution, but it addresses the conditions for synthesis rather than synthesis itself.
Phytoceramides (plant-derived glucosylceramides) work through a different route entirely. Absorbed as metabolic precursors in the small intestine, their sphingolipid breakdown products are taken up by keratinocytes and channelled into the salvage pathway, which regenerates ceramide without requiring de novo synthesis from scratch. Research shows oral GlcCer also upregulates filaggrin expression and glucosylceramide synthase activity; the skin is not just using the delivered building blocks passively, it is producing more of its own. Where omega-3s clear the road, phytoceramides help the skin start building again. [4]
Together as a Supplementation Protocol
These two approaches are additive rather than competing. In skin where type 2 inflammatory signalling is suppressing ceramide synthesis, taking omega-3s without phytoceramides addresses the cytokine environment but does not provide the salvage pathway substrates that accelerate ceramide recovery. Taking phytoceramides without omega-3s delivers building blocks into a system that may still be partially suppressed by ongoing inflammatory activity. Used together, they target both the upstream suppression and the downstream production simultaneously.
In practice, this means a 12-week minimum commitment to consistent daily supplementation for both, with the omega-3 anti-inflammatory effect accumulating over weeks as tissue EPA/ DHA levels increase, and the phytoceramide benefit building as the salvage pathway upregulation compounds with filaggrin and GlcCer synthase expression. The 31.9% hydration improvement from 12-week rice-derived GlcCer use reflects what consistent supplementation produces – not an effect that appears quickly.
Positioning Within a Complete Barrier Protocol
Internal supplementation occupies a specific and honest position within a barrier repair strategy. Topical multi-ceramide formulations with cholesterol and free fatty acids in physiological ratios address the structural deficit at the barrier directly and produce measurable TEWL improvements within two to four weeks. Professional treatments including thulium laser and microneedling activate the synthesis machinery from within the tissue. Oral supplementation works at a slower pace, building the biosynthetic foundations that sustain long-term barrier health rather than producing rapid acute repair.
For clients who want to support barrier health comprehensively, the supplement layer makes most sense as a sustained background strategy rather than a first-response repair tool. This is particularly valuable during hormonal transitions, periods of chronic stress, or for clients with persistently atopic-tendency skin where the inflammatory suppression of lipid synthesis is an ongoing challenge rather than an acute episode.
References
Ideta R, Sakuta T, Nakano Y, et al. (2011). Orally administered glucosylceramide improves the skin barrier function by upregulating genes associated with the tight junction and cornified envelope formation. Biosci Biotechnol Biochem, 75(8), 1516-23 . doi.org/10.1271/bbb.110215
Koikeda T, Tokudome Y, Okayasu M, et al. (2017). Effects of Peach (Prunus persica)-Derived Glucosylceramide on the Human Skin. Current Medicinal Chemistry, 17(1), 56-70 . doi.org/10.2174/1871522217666170906155435
Leo TK, Tan ESS, Amini F, et al. (2022). Effect of Rice (Oryza sativa L.) Ceramides Supplementation on Improving Skin Barrier Functions and Depigmentation: An Open-Label Prospective Study. Nutrients, 14(13) . doi.org/10.3390/nu14132737
Takeda S, Yoneda A, Miyasaka K, et al. (2022). Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides. Int J Mol Sci, 24(1) . doi.org/10.3390/ijms24010083
Also Known As
- Glucosylceramides
Learn More
This topic is discussed in 2 articles:
-
Plant-derived ceramides taken orally, with research showing improved skin hydration after 12 weeks of consistent supplementation.
-
Plant-derived ceramides (from wheat or rice) taken orally. A 12-week study using 1.8mg daily of rice-derived glucosylceramides showed 31.9% hydration improvement on arm and 22.8% on cheek.